Search results

Jump to navigation Jump to search

Page title matches

  • In [[medicine]], '''alfuzosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s. Uroxatral brand of alfuzosin was approved by the [[Food and Drug Administration]] in the [[United States
    1 KB (142 words) - 11:47, 2 February 2023
  • 112 bytes (13 words) - 00:47, 5 September 2009
  • Auto-populated based on [[Special:WhatLinksHere/Alfuzosin]]. Needs checking by a human.
    492 bytes (62 words) - 10:48, 11 January 2010

Page text matches

  • In [[medicine]], '''alfuzosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s. Uroxatral brand of alfuzosin was approved by the [[Food and Drug Administration]] in the [[United States
    1 KB (142 words) - 11:47, 2 February 2023
  • Auto-populated based on [[Special:WhatLinksHere/Alfuzosin]]. Needs checking by a human.
    492 bytes (62 words) - 10:48, 11 January 2010
  • {{r|Alfuzosin}}
    517 bytes (65 words) - 21:25, 11 January 2010
  • * [[Alfuzosin]] (Uroxatral) 10 mg - $121.85 for 30 tablets
    2 KB (288 words) - 11:04, 11 June 2010
  • ...aruwala PD, Mitchell ID, Shearer MG, Hargreave TB| title=Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, pl ...| author=McNeill SA, Hargreave TB, Roehrborn CG, Alfaur study group| title=Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a
    20 KB (2,770 words) - 14:35, 2 February 2023
  • {{r|Alfuzosin}}
    4 KB (505 words) - 16:36, 11 January 2010
  • ...n prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin. | journal=Urology | year= 2001 | volume= 57 | issue= 3 | pages= 459-65 | p ...CD006015 | pmid=20927745 | doi=10.1002/14651858.CD006015.pub3 }} </ref> [[Alfuzosin]] and [[finasteride]] are generic.
    16 KB (2,300 words) - 11:19, 5 April 2012
  • ...]], [[tolterodine]], [[valdecoxib]], [[sibutramine]], [[sunitinib]], and [[alfuzosin]].
    8 KB (985 words) - 19:04, 4 September 2013
  • ...]], [[tolterodine]], [[valdecoxib]], [[sibutramine]], [[sunitinib]], and [[alfuzosin]].
    8 KB (984 words) - 19:05, 4 September 2013
  • *[[Alfuzosin/Definition]]
    15 KB (1,521 words) - 09:02, 2 March 2024